focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 368.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.366%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 368.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Cash Tender Offer

21 Apr 2021 10:54

RNS Number : 1746W
Bank of Cyprus Holdings PLC
21 April 2021
 

Announcement

 

Results of Cash Tender Offer

 

 

Nicosia, 21 April 2021

 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014.

 

 

 

Bank of Cyprus Holdings Public Limited Company (the "Company" or "BOC Holdings" and, together with its subsidiary, Bank of Cyprus Public Company Limited (the "Bank"), and the Bank's subsidiaries, the "Group") announces today the results of the Bank's invitation (the "Offer") to holders of its outstanding €250 mn Fixed Rate Reset Tier 2 Capital Notes due January 2027 (ISIN: XS1551761569) (the "Existing Notes") to tender their Existing Notes for purchase by the Bank at a price of 105.50%. The Bank will also pay the accrued interest due on the Existing Notes until the settlement date.

 

The Bank received valid tenders of €207 mn in aggregate nominal amount, or 83%, of the Existing Notes, all of which were accepted by the Bank. As a result, the Bank will incur a cost of c.€11 mn in 2Q2021, forfeiting the relevant obligation for future coupon payments. The settlement of the Offer is expected to take place on 23 April 2021, after which €43 mn in aggregate nominal amount of the Existing Notes will remain outstanding.

 

Goldman Sachs International and HSBC acted as Dealer Managers.

 

The successful uptake of the Offer, in conjunction with the issue of €300 mn unsecured and subordinated Tier 2 Capital Notes (the "New Notes") demonstrate the Group's proactive management of its capital base by refinancing the Existing Notes at a significantly lower coupon rate and managing the associated carry cost of the Existing Notes. The issuance of the New Notes further enhances the Group's capital base and is expected to increase the Group's Total Capital ratio by c.100 bps to 19.7%1 pro forma for Helix 2.

 

For further information, please contact Investor Relations at investors@bankofcyprus.com.

 

 

 

[1] Based on the Group financial results as at 31 December 2020 pro forma for Helix 2.

 

 

 

 

 

 

 

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 95 branches in Cyprus, of which 11 operate as cash offices. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 3,573 staff worldwide. At 31 December 2020, the Group's Total Assets amounted to €21.5 bn and Total Equity was €2.1 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEPPUPACUPGUBG
Date   Source Headline
19th Nov 20218:25 amRNSDate of Announcement of 9M2021 FR
15th Nov 20217:00 amRNSAgreement for sale of a portfolio of NPLs
8th Nov 20214:41 pmRNSSecond Price Monitoring Extn
8th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Oct 20214:35 pmRNSPrice Monitoring Extension
8th Oct 202112:10 pmRNSBuyback of Tier 2 Capital Notes
7th Oct 202111:57 amRNSAppointment of New Director
30th Sep 20218:32 amRNSTR-1 Notification- Caius
16th Sep 20217:33 amRNSTR-1 Notification -Senvest
13th Sep 202112:00 pmRNSTR-1 Notification - Carval
9th Sep 20214:41 pmRNSSecond Price Monitoring Extn
9th Sep 20214:36 pmRNSPrice Monitoring Extension
8th Sep 20214:40 pmRNSSecond Price Monitoring Extn
8th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20219:13 amRNSTR-1 Notification - Caius
1st Sep 20218:39 amRNSDoc re. (1H2021 Investor Presentation)
1st Sep 20217:27 amRNSHalf-year Report -4
1st Sep 20217:20 amRNSHalf-year Report -3
1st Sep 20217:03 amRNSHalf-year Report -2
1st Sep 20217:02 amRNSDoc re. (1H2021 Investor Presentation)
1st Sep 20217:00 amRNS1H2021 Group Financial Results
1st Sep 20217:00 amRNSHalf-year Report -1
20th Aug 20218:53 amRNSDate of announcement of 1H2021 FR
23rd Jul 202110:55 amRNSRenewal of collective agreement
28th Jun 202111:24 amRNSCompletion of Project Helix 2 (Portfolios A and B)
23rd Jun 20219:38 amRNSDirector/PDMR Shareholding- Iordanou
16th Jun 20214:23 pmRNSIssue of Debt
16th Jun 20218:14 amRNSTR-1 Notification - Carval
9th Jun 202110:03 amRNSDirector/PDMR Shareholding
8th Jun 202110:14 amRNSDirector/PDMR Shareholding- Iordanou
4th Jun 202110:04 amRNSDirector/PDMR Shareholding- Iordanou
3rd Jun 20211:34 pmRNSDirector/PDMR Shareholding - Iordanou
2nd Jun 20218:35 amRNSDirector/PDMR Shareholding- Mr. Iordanou
2nd Jun 20218:32 amRNSDirector/PDMR Shareholding- Mr. Iordanou
2nd Jun 20218:31 amRNSDirector/PDMR Shareholding- Mr. Iordanou
1st Jun 20217:00 amRNSPDMR Notification of Transaction - Iordanou
28th May 20212:07 pmRNSAnnouncement
25th May 202112:34 pmRNSResult of AGM
25th May 20217:02 amRNSDoc re. (1Q2021 Investor Presentation)
25th May 20217:00 amRNS1Q2021 Group Financial Results
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
12th May 20217:09 amRNSDate of announcement of 1Q2021 FR
29th Apr 20214:40 pmRNSSecond Price Monitoring Extn
29th Apr 20214:35 pmRNSPrice Monitoring Extension
26th Apr 202110:17 amRNSNotice of AGM
21st Apr 202110:54 amRNSResults of Cash Tender Offer
20th Apr 20212:23 pmRNSIssue of Tier 2 Capital Notes - Replacement
16th Apr 20216:01 pmRNSIssue of Tier 2 Capital Notes
7th Apr 20211:18 pmRNSPillar 3 Disclosures 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.